Broadway Financial Reports $25.9M Goodwill Impairment, Material Weaknesses, and Sharp Rise in Non-Accrual Loans

summarizeSummary

Broadway Financial reported a significant net loss for Q3 2025, driven by a $25.9 million goodwill impairment charge. The company also disclosed material weaknesses in its internal controls over financial reporting and a substantial increase in non-accrual loans.

check_boxKey Events

• Goodwill Impairment

  The company recorded a $25.9 million non-cash goodwill impairment charge for the third quarter of 2025, reflecting a significant write-down of prior acquisition value.

• Material Weaknesses in Internal Controls

  Management identified material weaknesses in internal control over financial reporting, specifically related to the accounting for loan participations, identification of unusual equity-related contracts, and evaluation of collateral-dependent loans.

• Sharp Increase in Non-Accrual Loans

  Non-accrual loans surged to $13.5 million at September 30, 2025, a substantial increase from $264 thousand at December 31, 2024, indicating a significant deterioration in asset quality.

• Net Loss Attributable to Common Stockholders

  The company reported a net loss attributable to common stockholders of $24.6 million for Q3 2025 and $28.1 million for the first nine months of 2025, largely driven by the goodwill impairment.

auto_awesomeAnalysis

This 10-Q filing reveals severe financial and operational challenges for Broadway Financial. The $25.9 million goodwill impairment represents a substantial write-down of asset value, indicating that prior acquisitions are not performing as expected. Coupled with the disclosure of material weaknesses in internal controls over financial reporting, this raises significant concerns about the company's financial integrity and risk management. The dramatic increase in non-accrual loans further highlights a deteriorating asset quality trend, which could lead to higher future credit losses. Investors should view these disclosures as highly negative signals, suggesting fundamental issues that could impact future profitability and shareholder value. The ongoing need for restatements underscores a persistent lack of reliable financial reporting.